Public consultation on items to be considered by the PBAC (May 2022 Intracycle Meeting)

Closed 8 Apr 2022

Opened 11 Feb 2022


PBAC Intracycle meetings are held between the main PBAC meetings. Submission items considered by the PBAC at these meetings typically relate to matters arising from previous submissions but can also relate to new medicines.

The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration.

All public consultation inputs are considered by the PBAC when considering the clinical and economic evidence presented by the applicant.

  • Input can be submitted via the online survey which includes an option to upload a file. You can save and come back at any time to your response before the consultation close date.
  • Input can also be emailed to

For resubmission items listed on the PBAC Intracycle agenda, previous consultation input will be retained and considered by the PBAC.

What happens next

PBAC Outcomes are published to inform the public about the PBAC’s advice to the Minister for Health. The documents report the PBAC’s recommendation in each case and summarise the reasons for the advice. 

The PBAC outcomes  are available on the PBS website six (6) weeks after each PBAC meeting and can be found using the Medicine Status Website.

Further explanation of the PBAC outcome is available in the Public Summary Document. Public Summary Documents are available on the PBS website  approximately four (4) months after the PBAC meeting. See the PBAC calendar  for publication dates.


  • Anyone from any background


  • All